Showing results (211-220 of 237) with videos related to

Sort By:
Pageof 24
The American Journal of Cardiology|May 12, 2009
Comparative effect of atorvastatin (80 mg) versus simvastatin (20 to 40 mg) in preventing hospitalizations for heart failure in patients with previous myocardial infarctionTimo E Strandberg, Ingar Holme, Ole Faergeman, et al.
Journal of Internal Medicine|February 10, 2010
Cardiovascular outcomes and their relationships to lipoprotein components in patients with and without chronic kidney disease: results from the IDEAL trialI Holme, R Fayyad, O Faergeman, et al.
European Journal of Clinical Nutrition|February 14, 2008
Safety assessment of common foods enriched with natural nonesterified plant sterolsJ Tuomilehto, M J Tikkanen, P Högström, et al.
Transplantation|March 1, 1993
Long-term consequences of different immunosuppressive regimens for renal allograftsH M Isoniemi, J Ahonen, M J Tikkanen, et al.
The American Journal of Cardiology|February 24, 2009
Comparison of efficacy and safety of atorvastatin (80 mg) to simvastatin (20 to 40 mg) in patients aged or=65 years with coronary heart disease (from the Incremental DEcrease through Aggressive Lipid Lowering [IDEAL] study)Matti J Tikkanen, Ingar Holme, Nilo B Cater, et al.
The American Journal of Cardiology|July 21, 2010
Comparison of atorvastatin 80 mg/day versus simvastatin 20 to 40 mg/day on frequency of cardiovascular events late (five years) after acute myocardial infarction (from the Incremental Decrease in End Points through Aggressive Lipid Lowering [IDEAL] trial)Terje R Pedersen, Nilo B Cater, Ole Faergeman, et al.
Atherosclerosis|February 25, 1999
Association of FXIII Val34Leu with decreased risk of myocardial infarction in Finnish malesU Wartiovaara, M Perola, H Mikkola, et al.
The American Journal of Cardiology|September 18, 2004
Design and baseline characteristics of the Incremental Decrease in End Points through Aggressive Lipid Lowering studyTerje R Pedersen, Ole Faergeman, John J P Kastelein, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|March 27, 2009
Adherence-adjusted efficacy with intensive versus standard statin therapy in patients with acute myocardial infarction in the IDEAL studyIngar Holme, Michael Szarek, Nilo B Cater, et al.
The Journal of Clinical Endocrinology and Metabolism|June 23, 2012
Fatty acyl esterification and deesterification of 17β-estradiol in human breast subcutaneous adipose tissueFeng Wang, Veera Vihma, Maija Badeau, et al.
Pageof 24